Live tape.Join the lounge

Research with context.

A clearer way to explore the market.

Create an account Contact the team

Market signals, research, watchlists, and alerts in one workspace.

Follow the signal.

Product Pricing FAQ

Data coverage Methodology Disclosures Contact

© 2026 Longbrunch. All rights reserved.

longbrunch/

ROP.SW/Research

Fundamentals

Roche Holding AG · Equity

Partial coverage

TradeShort termMedium termLong term

Financial health Growth Valuation Profitability Shareholder return

Financial health

2 current metrics

Total Assets2025-12-31: 100.7B CHF
Total Liabilities2025-12-31: 62.82B CHF

Historical trendData pending

Growth

4 current metrics

Eps2026-07-31: 15.34
Free Cash Flow2026-07-31: 10.32B CHF
Net Income2025-12-31: 12.88B CHF
Revenue2025-12-31: 63.36B CHF

Historical trendData pending

Valuation

3 current metrics

Market Cap2026-07-31: 281.74B CHF
Trailing Pe2026-07-31: 23.050848
Trailing P/E: 23.05

Historical trendData pending

Profitability

3 current metrics

Ebitda2026-07-31: 23.96B CHF
Gross Profit2025-12-31: 46.71B CHF
Operating Income2025-12-31: 18.48B CHF

Historical trendData pending

Shareholder return

6 current metrics

Dividend Rate2026-07-31: 9.8
Dividend Yield2026-07-31: 2.77%
Ex Dividend Date2026-07-31: 2026-03-12
Payout Ratio2026-07-31: 63.89%
Trailing Annual Dividend Rate2026-07-31: 9.8
Trailing Annual Dividend Yield2026-07-31: 2.77%

Historical trendData pending

Financial evidence

Statement-level periods and line items live in the dedicated view.

Open Financial Statements →